Trials / Completed
CompletedNCT03669796
Marine Protein Hydrolysate as Dietary Supplement in Elderly Part I
A Study of the Effects of Marine Protein Hydrolysate as Dietary Supplement on the Regulation of Postprandial Blood Glucose Metabolism in Healthy Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 41 (actual)
- Sponsor
- Helse Møre og Romsdal HF · Other Government
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to investigate the potential effect of a marine protein hydrolysate (MPH) supplement before a meal on postprandial glucose tolerance in healthy subjects, to achieve more knowledge on this presumed beneficial, blood glucose lowering effect
Detailed description
To further investigate the effects of MPH in a single dose of 20 mg/kg of body weight on postprandial blood glucose, insulin and GLP-1 (as markers of glucose metabolism) in healthy, active middle-aged to elderly subjects - age 40-65 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Marine protein hydrolysate (mph) | Marine (Cod) protein hydrolysate |
| DIETARY_SUPPLEMENT | Control | Maltodextrin/Casein |
Timeline
- Start date
- 2017-11-27
- Primary completion
- 2018-02-28
- Completion
- 2018-02-28
- First posted
- 2018-09-13
- Last updated
- 2019-11-14
Locations
2 sites across 1 country: Norway
Source: ClinicalTrials.gov record NCT03669796. Inclusion in this directory is not an endorsement.